Why consumer healthcare innovator Kenvue can come good for investors
Kenvue (KVUE:NYSE) $24.30Market cap: $46.6 billionInvestors looking to add a resilient company with healthy global growth potential to portfolios should consider Kenvue (KVUE:NYSE). The $46.6 billion cap stands behind a variety of self-care, beauty and essential health products. Formerly Johnson & Johnson's (JNJ:NYSE) consumer healthcare division, Kenvue was spun out as a standalone in 2023 via a